Product Recalls: May 11, 2023 – June 14, 2023
Health Letter, July 2023
Note: Never stop taking a drug that appears on the product recall list without first talking to your doctor or pharmacist. Most recalls are limited to a single manufacturer and may not be related to the version of a particular drug you are taking. If a recall does relate to the version of the drug you are taking, you should not stop taking the drug until you discuss an alternative treatment with your doctor or pharmacist.
CLASS II
Acetaminophen caplets, 500 mg, 225-count bottles. Distributed by: Walgreen Co. Lot #: P2200101 or P2200178, exp. date: 11/2023; Lot #: P2200230, exp. date: 12/2023.
buPROPrion hydrochloride extended-release tablets, 150 mg, 60 tablets. Distributed by: Sun Pharmaceutical Industries, Inc. Manufactured by: Sun Pharmaceutical Industries Limited. Lot #: HAC2240A, exp. date: 05/2023; Lot #: HAC3162A, exp. date: 07/2023.
Glimepiride tablets; 1, 2 or 4 mg; 100- or 500-count bottle. Manufactured by: Intas Pharmaceuticals Limited. Lot #: P2002616, exp. date: 04/30/2023; Lot #: P2006509, exp. date: 11/30/2023; Lot #: P2103572, exp. date: 04/30/2024; Lot #: P2106811, exp. date: 09/30/2024; Lot #: R2200578, exp. date: 04/30/2025; Lot #: P2100095, exp. date: 11/30/2023; Lot #: P2100624, exp. date: 01/31/2024; Lot #: P2101780, exp. date: 02/29/2024; Lot #: P2107383, exp. date: 09/30/2024; Lot #: P2201505, exp. date: 02/28/2025; Lot #: R2201109, exp. date: 06/30/2025; Lot #: P2003493, exp. date: 05/31/2023; Lot #: P2100120, exp. date: 11/30/2023; Lot #: P2100683, exp. date: 01/31/2024; Lot #: P2106002, exp. date: 07/31/2024; Lot #: R2200148, exp. date: 12/31/2024; Lot #: R2201125, exp. date: 06/30/2025; Lot #: P2003403, exp. date: 05/31/2023; Lot #: P2005800, exp. date: 09/30/2023; Lot #: P2101156, exp. date: 01/31/2024; Lot #: P2105401, exp. date: 07/31/2024; Lot #: R2200083, exp. date: 12/31/2024; Lot #: R2201004, exp. date: 07/31/2025; Lot #: P2003403, exp. date: 05/31/2023; Lot #: P2006593, exp. date: 11/30/2023; Lot #: P2101152, exp. date: 01/31/2024; Lot #: P2105014, exp. date: 06/30/2024; Lot #: R2101440, exp. date: 09/30/2024; Lot #: P2200774, exp. date: 01/31/2025; Lot #: R2200664, exp. date: 04/30/2025; Lot #: P2100705, exp. date: 01/31/2024; Lot #: P2104672, exp. date: 06/30/2024; Lot #: R2101435, exp. date: 09/30/2024; Lot #: R2200102, exp. date: 12/31/2024; Lot #: R2200577, exp. date: 04/30/2025; Lot #: P2205870, exp. date: 08/31/2025; Lot #: P2100121, exp. date: 11/30/2023; Lot #: P2100705, exp. date: 01/31/2024; Lot #: P2104672, exp. date: 06/30/2024; Lot #: R2101435, exp. date: 09/30/2024; Lot #: R2200102, exp. date: 12/31/2024; Lot #: R2200577, R2200577 or P2205870, exp. date: 08/31/2025.
Rifampin capsules, 150 or 300 mg, 30- or 60-count bottles. Distributed by: Akorn Operating Company LLC. All Lots.
For more information about the drug recalls listed above, please visit http://www.accessdata.fda.gov/scripts/ires/index.cfm.
CONSUMER PRODUCTS
For a list of recent recalls of consumer products, please visit the Consumer Product Safety Commission website at http://www.cpsc.gov/en/Recalls/.